ReviewJournal of pain research2020

Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations.

Rafia Shafqat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.